Leerink Partners

General contacts

Investor type

Fund of funds

Founded

1995

AUM

$699 M

Location

New York, New York, United States

Investment Ticket

$5-10 m

Investment Stage

Series B Series A Seed Late Stage (Series C+)

Region of investment

North America Europe

Investor profile last updated: 16 August, 2026

Profile

Leerink Partners is a healthcare-focused investment bank headquartered in Boston, Massachusetts, founded in 1995. The firm is known for its specialized team of experts who provide advisory services in mergers and acquisitions, capital raising, and strategic financial solutions. With a team of 470 employees, Leerink Partners has established itself as a trusted partner for healthcare companies and their investors, leveraging decades of experience across biopharma, digital health, health tech, and medical technology sectors.

Leerink Partners primarily invests in the healthcare sector, focusing on biopharmaceuticals, medical devices, diagnostics, and healthcare services. The firm is involved in various stages of investment, including Series A and beyond, with typical check sizes ranging from $3 million to $10 million. Leerink Partners has raised over $206 billion in capital and completed 1,376 transactions as of June 2026. The firm manages funds such as Leerink Transformation Partners I and LEERINK Revelation Healthcare Fund I.

Notable investments by Leerink Partners include LB Pharmaceuticals - a company focused on psychiatric treatments, Vidya Therapeutics - specializing in innovative therapeutics, and Processa Pharmaceuticals - a biopharmaceutical company. The firm has also acted as a placement agent for companies like Entera Bio and Scribe Therapeutics, showcasing its extensive network and expertise in the healthcare investment landscape.

Industry

HealthTech MedTech Healthcare Services Digital Biotechnology Fashion/Beauty Medical Devices

Leerink Partners Funds

Name	Type	Industry	Stage	Region	Size	AUM	Launch date
Leerink Transformation Partners I	Fund of funds	Digital Fashion/Beauty Healthcare Services HealthTech	Seed Series A Series B	North America Europe	$5-10 m	$313 M	September 2017
LEERINK Revelation Healthcare Fund I	Fund of funds	Fashion/Beauty Healthcare Services Medical Devices HealthTech	Seed Series A Series B	North America Europe	$5-10 m	$192 M	May 2016

Contacts

Name

Title

Social Networks

Jeffrey Leerink Chairman and CEO Leerink Partners

Chairman and CEO Leerink Partners

j•••@•••

Shreyas Radhakrishna Vice President Healthcare Investment Banking

Vice President Healthcare Investment Banking

s•••@•••

Upgrade to see contacts

zVhfZRnrqmU2EOpk zVhfZRnrqmU2EOpk

zVhfZRnrqmU2EOpk

[email protected]

zVhfZRnrqmU2EOpk zVhfZRnrqmU2EOpk

zVhfZRnrqmU2EOpk

[email protected]

zVhfZRnrqmU2EOpk zVhfZRnrqmU2EOpk

zVhfZRnrqmU2EOpk

[email protected]

Investment-team contacts for Leerink Partners — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.

Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Leerink Partners

Is Leerink Partners a venture capital or private equity firm?

Leerink Partners operates as a fund of funds. It backs companies at Series B, Series A, Seed and Late Stage (Series C+), writing tickets of $5-10 m.

Where is Leerink Partners located?

Leerink Partners is located in New York, New York, United States.

When was Leerink Partners founded?

Leerink Partners was founded in 1995.

What sectors and industries does Leerink Partners invest in?

Leerink Partners invests in companies and startups in HealthTech, MedTech, Healthcare Services, Digital, Biotechnology, Fashion/Beauty, Medical Devices.

What is Leerink Partners geographical focus of investments?

Leerink Partners invests in companies and startups in North America, Europe.

At what stages of companies and startups does Leerink Partners typically invest in?

Leerink Partners invests in companies and startups at Series B, Series A, Seed, Late Stage (Series C+).

What is the usual amount of Leerink Partners investment?

Leerink Partners usually invests $5-10 m on average.

What is the amount of assets of under management (AUM) for Leerink Partners?

Leerink Partners has around $699m assets under management.

When was Leerink Partners last fund created?

Leerink Partners last fund was created/launched in 2017-09-12

What are the contacts of Leerink Partners?

Leerink Partners can be reached through its website leerink.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Leerink Partners — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

Can I access Leerink Partners data via API or MCP?

Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Leerink Partners directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.

When was the Leerink Partners profile last updated?

Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.